Skip to main content
. 2020 Jul 20;11(7):551. doi: 10.1038/s41419-020-02746-w

Fig. 4. Compound 5e inhibited mTOR activity via FKBP12.

Fig. 4

Western blot analysis of RPS6KB1, p-RPS6KB1, EIF4EBP1, and p-EIF4EBP1. a A549 cells were treated with compound 5e at indicated concentrations for 6 h along with pretreatment of 3BDO or not. The pretreatment time of 3BDO was 3 h and the concentration were 0.1, 1, and 30 μM respectively. b A549 cells were treated with compound 5e for 6 h in 10 μM solely or along with SiFKBP12 in 60 nM for 24 h. β-actin was used as a loading control. Results were presented as mean ± SE; n = 3; *p < 0.05; **p < 0.01.